Atrial fibrillation and thromboprophylaxis in heart failure: The need for patient-centered approaches to address adherence

Caleb Ferguson, Sally C. Inglis, Phillip J. Newton, Sandy Middleton, Peter S. Macdonald, Patricia M Davidson

Research output: Contribution to journalArticle

Abstract

Atrial fibrillation is a common arrhythmia in heart failure and a risk factor for stroke. Risk assessment tools can assist clinicians with decision making in the allocation of thromboprophylaxis. This review provides an overview of current validated risk assessment tools for atrial fibrillation and emphasizes the importance of tailoring individual risk and the importance of weighing the benefits of treatment. Further, this review provides details of innovative and patient-centered methods for ensuring optimal adherence to prescribed therapy. Prior to initiating oral anticoagulant therapy, a comprehensive risk assessment should include evaluation of associated cardiogeriatric conditions, potential for adherence to prescribed therapy, frailty, and functional and cognitive ability.

Original languageEnglish (US)
Pages (from-to)3-11
Number of pages9
JournalVascular Health and Risk Management
Volume9
Issue number1
DOIs
Publication statusPublished - 2013
Externally publishedYes

    Fingerprint

Keywords

  • Anticoagulation
  • Atrial fibrillation
  • Heart failure
  • Medication adherence
  • Risk stratification
  • Stroke risk

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)
  • Public Health, Environmental and Occupational Health
  • Hematology
  • Endocrinology, Diabetes and Metabolism

Cite this